ArticleInternational journal of clinical oncology2025

Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohort.

Ryoichi Saito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.